Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118808587> ?p ?o ?g. }
- W3118808587 endingPage "173875" @default.
- W3118808587 startingPage "173875" @default.
- W3118808587 abstract "Given that neuronal degeneration in Alzheimer's disease (AD) is caused by the combination of multiple neurotoxic insults, current directions in the research of novel therapies to treat this disease attempts to design multitarget strategies that could be more effective than the simply use of acetylcholinesterase inhibitors; currently, the most used therapy for AD. One option, explored recently, is the synthesis of new analogues of cannabinoids that could competitively inhibit the acetylcholinesterase (AChE) enzyme and showing the classic neuroprotective profile of cannabinoid compounds. In this work, molecular docking has been used to design some cannabinoid analogues with such multitarget properties, based on the similarities of donepezil and Δ9-tetrahydrocannabinol. The analogues synthesized, compounds 1 and 2, demonstrated to have two interesting characteristics in different in vitro assays: competitive inhibition of AChE and competitive antagonism at the CB1/CB2 receptors. They are highly lipophilic, highlighting that they could easily reach the CNS, and apparently presented a low toxicity. These results open the door to the synthesis of new compounds for a more effective treatment of AD." @default.
- W3118808587 created "2021-01-18" @default.
- W3118808587 creator A5016002172 @default.
- W3118808587 creator A5036189795 @default.
- W3118808587 creator A5040647496 @default.
- W3118808587 creator A5046358279 @default.
- W3118808587 creator A5046765889 @default.
- W3118808587 creator A5048918090 @default.
- W3118808587 creator A5052055862 @default.
- W3118808587 creator A5056470834 @default.
- W3118808587 creator A5062792978 @default.
- W3118808587 creator A5068058486 @default.
- W3118808587 creator A5069469607 @default.
- W3118808587 creator A5089622493 @default.
- W3118808587 date "2021-03-01" @default.
- W3118808587 modified "2023-10-12" @default.
- W3118808587 title "Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease" @default.
- W3118808587 cites W1987170637 @default.
- W3118808587 cites W2016091214 @default.
- W3118808587 cites W2025227826 @default.
- W3118808587 cites W2031507955 @default.
- W3118808587 cites W2032761582 @default.
- W3118808587 cites W2041094223 @default.
- W3118808587 cites W2044281547 @default.
- W3118808587 cites W2048306858 @default.
- W3118808587 cites W2053972194 @default.
- W3118808587 cites W2069294211 @default.
- W3118808587 cites W2071332665 @default.
- W3118808587 cites W2072721884 @default.
- W3118808587 cites W2078179976 @default.
- W3118808587 cites W2085724240 @default.
- W3118808587 cites W2085958374 @default.
- W3118808587 cites W2086288006 @default.
- W3118808587 cites W2087538505 @default.
- W3118808587 cites W2097802864 @default.
- W3118808587 cites W2112404540 @default.
- W3118808587 cites W2114918609 @default.
- W3118808587 cites W2132194615 @default.
- W3118808587 cites W2143209864 @default.
- W3118808587 cites W2146588392 @default.
- W3118808587 cites W2158534713 @default.
- W3118808587 cites W2170814076 @default.
- W3118808587 cites W2312123455 @default.
- W3118808587 cites W2531214067 @default.
- W3118808587 cites W2790631595 @default.
- W3118808587 cites W2807482700 @default.
- W3118808587 cites W2887287732 @default.
- W3118808587 cites W2905760655 @default.
- W3118808587 cites W2906630689 @default.
- W3118808587 cites W2949937187 @default.
- W3118808587 cites W2952306507 @default.
- W3118808587 cites W2976163884 @default.
- W3118808587 cites W2996080671 @default.
- W3118808587 cites W3042981350 @default.
- W3118808587 doi "https://doi.org/10.1016/j.ejphar.2021.173875" @default.
- W3118808587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33460612" @default.
- W3118808587 hasPublicationYear "2021" @default.
- W3118808587 type Work @default.
- W3118808587 sameAs 3118808587 @default.
- W3118808587 citedByCount "8" @default.
- W3118808587 countsByYear W31188085872021 @default.
- W3118808587 countsByYear W31188085872022 @default.
- W3118808587 countsByYear W31188085872023 @default.
- W3118808587 crossrefType "journal-article" @default.
- W3118808587 hasAuthorship W3118808587A5016002172 @default.
- W3118808587 hasAuthorship W3118808587A5036189795 @default.
- W3118808587 hasAuthorship W3118808587A5040647496 @default.
- W3118808587 hasAuthorship W3118808587A5046358279 @default.
- W3118808587 hasAuthorship W3118808587A5046765889 @default.
- W3118808587 hasAuthorship W3118808587A5048918090 @default.
- W3118808587 hasAuthorship W3118808587A5052055862 @default.
- W3118808587 hasAuthorship W3118808587A5056470834 @default.
- W3118808587 hasAuthorship W3118808587A5062792978 @default.
- W3118808587 hasAuthorship W3118808587A5068058486 @default.
- W3118808587 hasAuthorship W3118808587A5069469607 @default.
- W3118808587 hasAuthorship W3118808587A5089622493 @default.
- W3118808587 hasConcept C126322002 @default.
- W3118808587 hasConcept C148001335 @default.
- W3118808587 hasConcept C169760540 @default.
- W3118808587 hasConcept C170493617 @default.
- W3118808587 hasConcept C181199279 @default.
- W3118808587 hasConcept C185592680 @default.
- W3118808587 hasConcept C25498285 @default.
- W3118808587 hasConcept C2776885963 @default.
- W3118808587 hasConcept C2778816929 @default.
- W3118808587 hasConcept C2779046751 @default.
- W3118808587 hasConcept C2779059548 @default.
- W3118808587 hasConcept C2779134260 @default.
- W3118808587 hasConcept C2779483572 @default.
- W3118808587 hasConcept C2780871563 @default.
- W3118808587 hasConcept C2780904820 @default.
- W3118808587 hasConcept C46721173 @default.
- W3118808587 hasConcept C55493867 @default.
- W3118808587 hasConcept C71924100 @default.
- W3118808587 hasConcept C86803240 @default.
- W3118808587 hasConcept C98274493 @default.
- W3118808587 hasConceptScore W3118808587C126322002 @default.
- W3118808587 hasConceptScore W3118808587C148001335 @default.